Archaebiotics: Proposed therapeutic use of archaea to prevent trimethylaminuria and cardiovascular disease

Trimethylamine (TMA) is produced by gut bacteria from dietary ingredients. In individuals with a hereditary defect in flavin-containing monooxygenase 3, bacterial TMA production is believed to contribute to the symptoms of trimethylaminuria (TMAU; fish-odor syndrome). Intestinal microbiota TMA metab...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Brugère, Jean-François, Borrel, Guillaume, Gaci, Nadia, Tottey, William, O’Toole, Paul W, Malpuech-Brugère, Corinne
Format: Artigo
Idioma:Inglês
Publicat: Landes Bioscience 2014
Matèries:
Commentary and Views
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4049937/
https://ncbi.nlm.nih.gov/pubmed/24247281
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/gmic.26749
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars